Roadzen (NASDAQ:RDZN - Get Free Report) had its target price reduced by equities researchers at Maxim Group from $7.00 to $4.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has a "buy" rating on the stock. Maxim Group's price target would indicate a potential upside of 387.80% from the company's previous close.
Separately, ThinkEquity assumed coverage on shares of Roadzen in a research note on Monday, October 28th. They issued a "buy" rating and a $6.00 price target for the company.
Read Our Latest Stock Analysis on RDZN
Roadzen Price Performance
Shares of RDZN traded up $0.01 during trading hours on Friday, hitting $0.82. 54,736 shares of the stock were exchanged, compared to its average volume of 633,314. Roadzen has a fifty-two week low of $0.71 and a fifty-two week high of $7.17. The business has a 50-day moving average of $1.08 and a 200-day moving average of $1.98. The firm has a market capitalization of $56.12 million, a P/E ratio of -0.43 and a beta of 0.66.
Roadzen (NASDAQ:RDZN - Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The company reported ($0.46) EPS for the quarter. Roadzen had a negative net margin of 290.14% and a negative return on equity of 31,166.20%. The business had revenue of $8.93 million for the quarter.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Murchinson Ltd. acquired a new position in Roadzen during the second quarter valued at $100,000. Bank of New York Mellon Corp acquired a new position in shares of Roadzen in the second quarter worth $59,000. Finally, Rhumbline Advisers purchased a new stake in Roadzen during the 2nd quarter worth about $39,000. Hedge funds and other institutional investors own 24.73% of the company's stock.
Roadzen Company Profile
(
Get Free Report)
Roadzen, Inc, an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Roadzen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roadzen wasn't on the list.
While Roadzen currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
